Kevin C. Oboyle, Director at GenMark Diagnostics, Inc. (GNMK), bought 4,500 shares at $6.71 ($30K) on 2015-11-03, disclosed to the SEC on 2015-11-04.
Open-market purchase of $30k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2019-08-19 | $225K | — | Filing → |
| SIEN | BUY | 2019-06-11 | $50K | — | Filing → |
| NVRO | BUY | 2019-06-07 | $101K | — | Filing → |